Development of siRNA-based therapeutics

被引:0
|
作者
Polisky, Barry [1 ]
机构
[1] Sirna Therapeut, Boulder, CO 80302 USA
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:2A / 2A
页数:1
相关论文
共 50 条
  • [1] Preclinical and clinical development of siRNA-based therapeutics
    Ozcan, Gulnihal
    Ozpolat, Bulent
    Coleman, Robert L.
    Sood, Anil K.
    Lopez-Berestein, Gabriel
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 : 108 - 119
  • [2] Advances in the development of siRNA-based therapeutics for cancer
    Shen, Yu
    [J]. IDRUGS, 2008, 11 (08) : 572 - 578
  • [3] Nanoparticle delivery systems for siRNA-based therapeutics
    Li, Jinming
    Xue, Shanshan
    Mao, Zong-Wan
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2016, 4 (41) : 6620 - 6639
  • [4] Safety of antisense oligonucleotide and siRNA-based therapeutics
    Chi, Xuan
    Gatti, Philip
    Papoian, Thomas
    [J]. DRUG DISCOVERY TODAY, 2017, 22 (05) : 823 - 833
  • [5] Cellular Delivery In Vivo of siRNA-Based Therapeutics
    Aigner, A.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (34) : 3603 - 3619
  • [6] Lipid nanoparticle delivery systems for siRNA-based therapeutics
    Wan, C.
    Allen, T. M.
    Cullis, P. R.
    [J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2014, 4 (01) : 74 - 83
  • [7] Interfering with disease: a progress report on siRNA-based therapeutics
    de Fougerolles, Antonin
    Vornlocher, Hans-Peter
    Maraganore, John
    Lieberman, Judy
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (06) : 443 - 453
  • [8] The growth of siRNA-based therapeutics: Updated clinical studies
    Zhang, M. May
    Bahal, Raman
    Rasmussen, Theodore P.
    Manautou, Jose E.
    Zhong, Xiao-bo
    [J]. BIOCHEMICAL PHARMACOLOGY, 2021, 189
  • [9] Lipid nanoparticle delivery systems for siRNA-based therapeutics
    C. Wan
    T. M. Allen
    P. R. Cullis
    [J]. Drug Delivery and Translational Research, 2014, 4 : 74 - 83
  • [10] Interfering with disease: a progress report on siRNA-based therapeutics
    Antonin de Fougerolles
    Hans-Peter Vornlocher
    John Maraganore
    Judy Lieberman
    [J]. Nature Reviews Drug Discovery, 2007, 6 : 443 - 453